Infomedia Ltd (ASX: IFM) is accelerating its AI-powered future, announcing a 50% acquisition of Intellegam GmbH, a European automotive AI startup, for €6.1 million. This move strengthens Infomedia’s innovation agenda,…
Artrya Secures $15M to Fast-Track AI-Driven Coronary Disease Tech
Artrya Limited (ASX: AYA) has locked in $15 million through a two-tranche placement at $0.73 per share, raising funds to accelerate regulatory approvals, commercial adoption, and clinical studies for its…
Temple & Webster Delivers Record Half-Year Results Amid Market Challenges
Temple & Webster (ASX: TPW) has once again delivered record-breaking results, with revenue surging 24% to $314 million for the half-year ending December 2024. Despite ongoing economic headwinds, the company…
Domain Delivers Strong Growth in H1 FY25, Profit Jumps 28%
Domain Holdings Australia (ASX: DHG) has kicked off the year with an impressive first-half performance, reporting a 7% increase in revenue to $217.2 million and a 28% jump in net…
CBA Delivers Solid 1H25 Results Amid Economic Challenges
Commonwealth Bank of Australia (ASX: CBA) has reported a strong financial performance for the first half of FY25, despite ongoing economic headwinds. The bank’s results highlight its disciplined approach to…
Clarity Pharmaceuticals Expands Breast Cancer Pipeline with Cu-64/67 SAR-trastuzumab
Clarity Pharmaceuticals is ramping up its efforts in the breast cancer treatment space with the addition of 64/67Cu-SAR-trastuzumab to its Targeted Copper Theranostic (TCT) portfolio. The company recently published pre-clinical…
CSL’s Solid Half-Year Results: Strong Performance Despite Challenges
CSL Limited has delivered a strong performance for the first half of the 2025 financial year, reporting a net profit after tax (NPAT) of $2.01 billion, a 6% increase year-on-year….
Alcidion Expands into Wales with Landmark Health Tech Deal
Alcidion (ASX:ALC) has just landed its first-ever contract in Wales, partnering with Hywel Dda University Health Board to roll out its Miya Precision Platform. This deal, valued at $5.5 million…
Generation Development Group to Acquire Evidentia for $320M, Launches $287.9M Equity Raising
Generation Development Group Limited (ASX: GDG) has announced a $320 million acquisition of Evidentia Group Holdings Pty Ltd, a leading Australian investment management and managed accounts provider. The deal will…
CLINUVEL Reports Positive Preliminary Results for SCENESSE® in Adolescent EPP Patients
CLINUVEL (ASX: CUV) has released promising preliminary results from its CUV052 study, evaluating SCENESSE® (afamelanotide) in adolescent patients (12–17 years old) with erythropoietic protoporphyria (EPP). The study confirms that the…